Top Stock Picks by Market Experts for 3 June

Top three stocks recommended by ankush bajaj for 3 June

Buy: Bank of India (Current Price: 125.25)

Why it’s recommended: The stock has recently shown Strong Upward Momentum and is Trading Near Breakout Levels with Increasing Volume, Indicating Buying Interest and Potential Continuation TOWARDS Higher Targets.
Key metrics: Resistance Level: 133-135 (short-term target range); support level: 121 (pattern invalidation level); Pattern: Bully Continuation with Strong Momentum and Volume Confirmation
RSI: Trending bulish on bot daily and intraday charts, signaling strength in the ongoing move
Technical analysis: Bank of India is trading with positive bias and has mained Higher highs and higher lows on the lower time frames. The current price action near 125.25, supported by Strong RSI, sugges the stock count test the 133-135 zone in the coming sessions if it sustains Above the breakout level.
Risk factors: A breakdown beLow 121 Cold Invalidate the Bulish Setup and Attract Profit Booking. Any sharp correction in the psu banking space or broader indices may impact the expected move.
Buy at, 125.25
Target price: 133-135 in 4-5 days
Stop Loss: 121

Buy: Cholamandalam Investment & Finance Co. LTD (Current Price: 1,581)

Why it’s recommended: After making a new lifetime high, the stock witnessed seling pressure and has now bounced back from the demand zone between 1,580–1,545. This sugges a potential pullback move, supported by price action and recover from key support levels.
Key metrics: Resistance level: 1,650-1,670 (short-term target range. Support level: 1,547 (pattern invalidation level); Pattern: Bullish Pullback Setup from Demand Zone
RSI: Bully on both daily and intraday time frames, supporting the possibilities of a short-term upside move
Technical analysis: Cholafin has shown strength by rebounding from its demand zone, and the current price structure indicates a likely pulback towards the 1,650-1,670 zone. Sustaining Above 1581 with improving Momentum supports a bullish Outlook in the Near Term.
Risk factors: A breakdown beLow 1,547 may invalidate the expected pullback. Broader Market Weakness or Negative Cues from the Financial Sector Could also Weigh on Price Action.
Buy at, 1,581
Target price: 1,650-1,670 in 4-5 days
Stop Loss: 1,547

Buy: AU Small Finance Bank Ltd (Current Price: 718.65)

Why it’s recommended: On the daily chart, the stock has closed Above a recent trendline, confirming a breakout. Additionally, on the 45-minute time frame, Aubank has given a triangle breakout at 700, Projecting a Potential Target Around 745. The setup indicates that ongoing rally is likely to continue.
Key metrics: Resistance Level: 738-745 (short-term target range); Support level: 708 (pattern invalidation level); Pattern: Trendline Breakout on Daily Chart and Triangle Breakout on 45-minute
RSI: Bully on both daily and lower time frames, supporting strength in the break
Technical analysis: Aubank has confirmed a breakout on Multiple Time Frames, Showing Strong Bully. The price action Above 718.65, Backed by Volume and Momentum, Supports Further UPSIDE TOWARD The Projected Targets.
Risk factors: A Fall Bellow 708 Cold Invalidate the Breakout Structure. Broader Banking Sector Weakness or Negative News Flow May Affect Short-Term Sentimen.
Buy at, 718.65
Target price: 738-745 in 4-5 days
Stop Loss, 708

Two stock recommendations for today, 3 June, by marketsmith india

Buy: Excel Industries Ltd. (Current Price: 1,218.80)

Why it’s recommended: DIVESE Product Portfolio Across High-Growth Sector, Strong Legacy, and Indigenous Innovation.

Key metrics: P/e: 17.02, 52-wheek high: 1,760.00, volume: 4.92 Crore

Technical analysis: Trendline Breakout

Risk Factors: High Dependence on Agrochemical Sector, Raw Material Price Volatily

Buy at, 1,218.80

Target price, 1,450 in three months

Stop Loss, 1,110

Buy: AU Small Finance Bank LTD (Current Price: 718.65)

Why it’s recommended: Strong Focus on Underserved Markets, Diversified Loan Book.

Key metrics: P/e: 24.51, 52-wheek high: 810, Volume: 459.59 Crore

Technical analysis: Bulish Flag Pattern Breakout

Risk Factors: Geographical Concentration Risk, Asset Quality Risks in MSME and Vehicle Finance

Buy at, 718

Target price, 790 in three months

Stop Loss, 690

Stocks to trade today, recommended by Trade Brains Portal for 3 June

Dr. Lal Pathlabs Ltd

Current price, 2,777

Target price, 3,380 in 16-24 months

Stop-Loss, 2,475

Why it’s recommended: Founded in 1949, Dr. Lal Pathlabs is One of India’s Leading Diagnostic Chains, Offering a Comprehensive Range of Pathology and Radiology Services. Its Pan-India PRESENCE Includes 12,365 Pick-up Points (PUPS), 6,607 Patient Service Centers (PSCs), and 298 Clinical Laboratories as of FY25. The Company Serves Patients and Healthcare Providers with Over 3,100 Pathology Tests, 1,400+ radiology/Cardiology Tests, and 385 Test Panels, Operating Across Across more than 23 Countries.

Key operational strengths

A Logistics Backbone Supported By 280+ Satellite Labs and 36 NABL Accredations.

Partnerships with 150+ Hospitals/Labs.

A Medical Team of 250+ Physicians and 1,800+ Employees.

Financial Highlights (FY25)

Revenue: 2,461 Crore, up 10.5% yoy

Ebitda: 696 Crore, up 14.2%, with 28.3% margin

PAT: 492 Crore, Up 35.9%, with A 20% Net Margin

The management is guiding for 11–12% Revenue Growth in FY26, Driven by Test Portfolio Expantion and Rising Patient Volumes. Ebitda margins are expected to hover Around 27%, as the company invests in growth regions (especially south and west India), Digital infrastructure, and talent acquestion.

Growth strategy

Continued focus on digital expansion, including an ai-spoken recommendation engine to improve patient experience.

Increasing Depth in High-Growth Segments Such as Genomics, Autoimmune Disorders, and Reproductive Diagnostics.

Accelerated presence in Tier-3 and Tier-4 Cities, Particularly in North and East India; 18 new labs added in fy25.

Ongoing Integration of Suburban Diagnostics (Acquired in 2021) to broaden revenue and service offers.

Emphasis on Volume-Led Growth by Increasing Bot Patient Footfall and Tests Per Patient.

Actively exploring inorganic growth options through M & A, Leveraging Its Strong Brand Recall.

Risk Factors: The accuracy of diagnostic services is critical. Any lapses due to operational errors, poor maintenance, or mishandling cough damage reputation and trust. The diagnostic space remains fragmented and highly competitive, with pricing pressure from numerous unorganized Players offering similar services.

Mahindra & Mahindra Financial Services Ltd

Current price, 260

Target price, 310 in 16-24 months

Stop-Loss, 230

Why it’s recommended: Establed in 1991, Mahindra Finance is Among India’s Leading Non-Banking Financial Companies (NBFCs), Catering to a wide customer base across rural and semi-surban india. The company operates a Robust Pan-India Network With Over 1,365 Branchs Across 27 States and 7 Union Territories, Covening 516,000 Villages and 8,000 Villages and 8,000 Towns, and served 11 millions of Customers CUSTOMERS CUSTOMERS Thrurs and 10 Ome Partnerships.

Its Diverse Portfolio Spans Vehicle Loans, SME Financing, Home Finance, Insurance Broking, Mutual Funds, Personal Loans, and Fixed Deposits, with an aum of $ 14.1 billion.

Financial Highlights (FY25)

Total disbursions: 60,741 Crore, up from 58,647 Crore in FY24

Profit after tax: 2,261 Crore, up 16% yoy

Total Income: 18,530 Crore, up 16% yoy

Loan book: 1,16,214 Crore, up 17% yoy

Interest Income: 16,566 Crore, up 15% yoy

Interest Expenses: 8,415 Crore, up 21% yoy

The company maintained healthy asset quality, supported by a tech-line approach to underwriting and collections. Credit Cost Study at 1.3%, NET Interest Margin at 6.5%, Gross Stage 3 (GS3) Assets at 3.7%.

Growth drivers

Mahindra Finance has focused on targeting resilient borrows, digitizing processes via third-party api integrations, and using data analytics to drive collection efficiency. The company’s sme segment saw a 48% jump in disbursions, accounting for 5% of the total. Among vehicles:

Passenger cars rose 8%, Making up 41% of disbursions

Tractor Loans Grew 3%, Contributing 10%

Pre-Owned and Three-WHEELER Financing Accounted for 16% and 4%, Respectly

Commercial Vehicle Financing Remained Stable at 21%

Other segments (Farm Implements, Gensets, Personal/Consumer Loans) Grew 21%, Contributing 2%

Mahindra Finance’s Diversified Portfolio and Strong Brand in Rural Markets Position It Well to Benefit from Increased Rural Spending and the UPTICK in Auto and Sme Finanking.

Risk Factors: Credit Risk Remains A Concern, Particularly in Rural Markets, Where Loan Delinquencies Cold Lead to Higher NPAS and Impact Profibility. The company’s dependence on Multiple Funding Sources Exposes IT to Liquidity Risks, Especially during during during the during the Financial Market Stress. Continued Performance Depends on Effective Risk Management, Prudent Capital Allocation, and Strong Administrative Controls.

Ankush bajaj is a sebi-regified research analyst. His registration number is inh000010441.

Marketsmith India: Trade Name: William O’neil India Pvt. Ltd; SEBI-Registerde Research Analyst Registration Number: Inh000015543

Trade brains portal is a stock analysis platform. Its Trade Name is Dailyraven Technologies Pvt. Ltd, and its sebi-registred research analyst registration number is inh000015729.

Investments in Securities are Subject to Market Risks. Read all the related documents carefully Before Investing. Registration Granted by Sebi and Certification from Nism in No Way Guarantees Performance of the Intermediary or Provide any Assurance of Returns to Investors.

Disclaimer: The Views and recommendations giving in this article are there that of individual analysts. These do not represent the views of Mint. We Advise Investors to Check With Certified Experts Before Making Any Investments Decisions.

Source link